Navigation Links
Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
Date:10/10/2011

FREMONT, Calif. and TOKYO, Oct. 10, 2011 /PRNewswire/ -- Zosano Pharma, Inc. (Zosano) and Asahi Kasei Pharma Corporation (AKP) announced today that they have entered into a long-term strategic collaboration for the development, commercialization and supply of a weekly transdermal patch formulation of Teribone™ (teriparatide acetate), AKP's formulation of human parathyroid hormone (human PTH 1-34), for the treatment of osteoporosis patients with a high risk of fracture. 

Under the terms of the agreement, AKP has received exclusive rights to develop and commercialize the transdermal patch formulation of Teribone™ in Japan, Korea, China and Taiwan.  AKP is responsible for clinical and regulatory development and commercialization activities. The transdermal patch product uses Zosano's patented, clinically validated, and GMP manufactured microprojection technology (known as ZP Patch Technology) to administer human PTH (1-34) through the skin.  It is expected to offer the benefits of self-administration, weekly dosing, room temperature stability, and pain-free delivery without the need for an injection.

The Agreement was signed on February 22, 2011, although AKP and Zosano agreed not to disclose the Agreement until the subcutaneous injection form of Teribone™ for osteoporosis patients was approved in Japan, which occurred on September 26, 2011. With the development of a microprojection patch formulation of Teribone™, AKP is further reinforcing both its R&D pipeline and its commitment to patients in the field of orthopedics, especially in the area of osteoporosis. 

"AKP and Zosano have joined their world-class and complementary assets to create what we believe has the opportunity to be the best in class product for bone growth in severe osteoporosis patients," said Gail Schulze, Chief Executive Officer of Zosano. "We believe this relationship will provide a product with superior fracture reduct
'/>"/>

SOURCE Zosano Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
2. Enox Biopharma, Inc. Will Be Granted its Foundation Patent
3. BD Announces Agreement to Acquire Carmel Pharma, Inc.
4. SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
5. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
6. Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference
7. Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices
8. PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015
9. SCOLR Pharma, Inc. First Quarter 2011 Financial Results
10. SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
11. Plato BioPharma, Inc. Sponsors Novel Disease Model Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Calif. , Oct. 31, 2014 ThynkWare ... sclerosis (ALS) patients initiate text and email messages using ... a patent-pending technology invented by ThynkWare,s founder, Duane ... on a smartphone device. This technology allows users to ... only the power of thought. ThynkWare provides ...
(Date:10/31/2014)... Migranade, Inc. announced today the new migraine ... 36 million U.S. migraine sufferers November, 2014. The medicine ... actual cause of migraines and not just the symptoms. ... source Migranade is assured to be a game changer ... available at http://www.migranade.com and will soon hit ...
(Date:10/31/2014)... NORTH CHICAGO, Ill., Oct. 31, 2014  AbbVie ... results for the third quarter ended Sept. 30, ... the strong performance of our business with double-digit ... Our underlying business grew nearly 14 percent in ... chairman and chief executive officer, AbbVie.  "We exceeded ...
Breaking Medicine Technology:ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2Game Changing Migraine Medication To Be Available November 2014 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
... Texas, Oct. 4, 2011 Today, Children,s ... in the state and the only stand-alone facility between Dallas ... Earlier, hospital personnel used Scott & White,s state-of-the-art Simulation Center ... Hospital, which was housed in Scott & White Hospital-Temple, before ...
... OTCQX: RHHBY) announced plans today to expand its coagulation testing ... clinics with the development of a full line of coagulation ... expected to be introduced in the U.S. and Canada in ... Roche Diagnostics is the global market leader in coagulation ...
Cached Medicine Technology:Children's Hospital at Scott & White Opens 2Children's Hospital at Scott & White Opens 3Children's Hospital at Scott & White Opens 4Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014 2
(Date:10/31/2014)... Energy Textiles has recently added a ... is now available online, and Energy Textile is providing ... infrared-active athletic gear over compression gear. , The ... been signed for Under Armour to provide team gear ... years. In light of this decision, Energy Textiles contemplates ...
(Date:10/31/2014)... (HealthDay News) -- Sleep apnea may make it hard for ... your car or left your house keys, a small study ... showed that this ability -- called spatial memory -- was ... even when other stages of sleep weren,t affected. REM sleep ... occur. "We,ve shown for the first time that sleep ...
(Date:10/31/2014)... duration of treatment and cost, patients with early ... breast irradiation (APBI) with proton therapy versus whole ... The University of Texas MD Anderson Proton Therapy ... study based on typical patient characteristics, researchers used ... eight different types of partial and whole breast ...
(Date:10/31/2014)... out of four older Americans say that either they ... medical treatment, according to the latest issue of The ... Report ( PP&AR ), which goes on to ... they fail to honor patients, end-of-life health care wishes. ... Care: Issues and Options ," features 12 articles that ...
(Date:10/31/2014)... Gold Medal Wine Club is making ... gifts for the wine novice and enthusiasts on their lists ... Special , which Early Bird shoppers receive discounts as high ... membership. , Gift Givers must place their orders before ... discounts, Gold Medal Wine Club adds more value to its ...
Breaking Medicine News(10 mins):Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Advance directives can benefit patients, families, and health care system 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2
... treatment, radiation may be a better choice than ... cancer, //according to a randomized controlled trial published ... The authors suggest that a combination of chemotherapy ... for these patients. ,Approximately 80 percent of ...
... finds that survivors of acute lymphoblastic leukemia have a ... the general population. // ,Acute lymphoblastic leukemia is ... almost 4,000 new cases diagnosed in the United States ... curable pediatric cancers: survival rates for patients who receive ...
... a weekly treatment with a nasal spray of virus enzymes ... based on results of a study. Such a treatment would ... avoiding the problem of antibiotic resistance. ,Middle ear ... the middle ear space that can cause pain, fever, irritability, ...
... the state government on a public suit demanding// protection ... litigation (PIL), filed by an NGO, Health, Environment and ... to be protected from silicosis, which is rife due ... malpractice of the mine owners. ,"We had ...
... Pitt donated $100,000 of their money to help// construct the ... ,They made the donation to the Duk Lost Boys Clinic ... in the spring and serve more than 150,000 people. ... of the "lost boys" of Sudan who is the director ...
... urged governments to join the anti-tuberculosis global plan, which ... the disease has become extremely drug-resistant. ,Ban's ... Day on Saturday. The World Health Organization (WHO) recently ... strain of tuberculosis, XDR-TB, which threatens to derail efforts ...
Cached Medicine News:Health News:Radiation Preferred Over Surgery for Patients With Some Stages of Lung Cancer 2Health News:Lymphoblastic Leukemia Survivors at Risk for Secondary Cancer 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 2Health News:Viral Enzyme Recruited in Fight Against Ear Infection 3Health News:Public Interest Litigation Filed Favoring Mineworkers Against Silicosis 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: